| P50 | author | Daria Mochly-Rosen | Q56073232 |
| P2093 | author name string | Kenneth I. Weinberg | |
| | Lauren D. Van Wassenhove | |
| P2860 | cites work | Aplastic anemia | Q81025689 |
| | Aldehyde dehydrogenase-2 polymorphism contributes to the progression of bone marrow failure in children with idiopathic aplastic anaemia | Q85289952 |
| | The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption | Q21144641 |
| | Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2 | Q24294750 |
| | The mutation in the mitochondrial aldehyde dehydrogenase (ALDH2) gene responsible for alcohol-induced flushing increases turnover of the enzyme tetramers in a dominant fashion | Q24318592 |
| | Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals | Q24598439 |
| | Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant | Q24611914 |
| | Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant | Q24628653 |
| | Acetaldehyde stimulates FANCD2 monoubiquitination, H2AX phosphorylation, and BRCA1 phosphorylation in human cells in vitro: implications for alcohol-related carcinogenesis | Q24645589 |
| | Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily | Q24655095 |
| | Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart | Q24656840 |
| | Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells | Q24676524 |
| | Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant | Q27658903 |
| | Kinetic mechanism of human glutathione-dependent formaldehyde dehydrogenase | Q28138054 |
| | Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application | Q28265682 |
| | Catalytic contribution of threonine 244 in human ALDH2 | Q28282806 |
| | Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems | Q28592801 |
| | Quantitative determination of acetaldehyde in foods using automated digestion with simulated gastric fluid followed by headspace gas chromatography | Q28743174 |
| | Formaldehyde exposure in U.S. industries from OSHA air sampling data | Q31162246 |
| | The kinetics of platelet production and destruction in man | Q33499139 |
| | Activation of aldehyde dehydrogenase 2 (ALDH2) confers cardioprotection in protein kinase C epsilon (PKCvarepsilon) knockout mice | Q33724453 |
| | Interactions of retinoid binding proteins and enzymes in retinoid metabolism | Q33751879 |
| | Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target? | Q33797190 |
| | Dark Hydrazone Fluorescence Labeling Agents Enable Imaging of Cellular Aldehydic Load. | Q33887825 |
| | The incredible journey: From megakaryocyte development to platelet formation. | Q34037117 |
| | Pattern of malformation in offspring of chronic alcoholic mothers | Q34051640 |
| | The Genetics of Fetal Alcohol Spectrum Disorders | Q38819476 |
| | The Fanconi anaemia pathway: new players and new functions | Q38825562 |
| | A Reaction-Based Fluorescent Probe for Imaging of Formaldehyde in Living Cells | Q38840926 |
| | Lidamycin inhibits tumor initiating cells of hepatocellular carcinoma Huh7 through GSK3β/β-catenin pathway | Q39125457 |
| | Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells | Q39669262 |
| | The in vitro production and characterization of neutrophils from embryonic stem cells | Q40629230 |
| | Formaldehyde exposure during pregnancy. | Q41005580 |
| | Racial differences in alcohol sensitivity: A new hypothesis | Q41031091 |
| | Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene | Q41649543 |
| | Phenotype prediction of deleterious nonsynonymous single nucleotide polymorphisms in human alcohol metabolism-related genes: a bioinformatics study | Q42922021 |
| | Determination of formaldehyde in blood plasma by high-performance liquid chromatography with fluorescence detection. | Q43595930 |
| | Human liver aldehyde dehydrogenase in Chinese and Asiatic Indians: Gene deletion and its possible implications in alcohol metabolism | Q43617790 |
| | New DNA adducts of crotonaldehyde and acetaldehyde | Q43716903 |
| | Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience | Q44024539 |
| | Isozyme variations in acetaldehyde dehydrogenase (e.c.1.2.1.3) in human tissues | Q44935938 |
| | Tissue-distribution of aldehyde dehydrogenase 2 and effects of the ALDH2 gene-disruption on the expression of enzymes involved in alcohol metabolism | Q45166485 |
| | The influence of genetic polymorphisms in XRCC3 and ADH5 genes on the frequency of genotoxicity biomarkers in workers exposed to formaldehyde. | Q45423693 |
| | P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells | Q45871082 |
| | Retinoic acid signaling is essential for embryonic hematopoietic stem cell development | Q46331596 |
| | The epidemiology of acquired aplastic anemia | Q46672372 |
| | An Aza-Cope Reactivity-Based Fluorescent Probe for Imaging Formaldehyde in Living Cells | Q46679610 |
| | Genotoxicity of alcohol is linked to DNA replication-associated damage and homologous recombination repair. | Q51756134 |
| | Crosstalk between the nucleotide excision repair and Fanconi anemia/BRCA pathways. | Q53055377 |
| | Fetal Alcohol Spectrum Disorders. | Q53306184 |
| | Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. | Q54035186 |
| | Cancer incidence in persons with Fanconi anemia. | Q55036178 |
| | Of mice and men...and elephants | Q57867822 |
| | Epidemiology of aplastic anemia: a prospective multicenter study | Q58863924 |
| | The fetal alcohol syndrome: clinical delineation | Q66865107 |
| | Compendium on shortness of stature | Q72205819 |
| | Bone marrow transplantation for Fanconi anemia. Adjustment of the dose of cyclophosphamide for preconditioning | Q72543103 |
| | Isolation and characterization of aldehyde dehydrogenase isozymes from usual and atypical human livers | Q72698314 |
| | Dry cleaning, some chlorinated solvents and other industrial chemicals. Lyon, France, 7-14 February 1995 | Q73315147 |
| | Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia | Q74541258 |
| | Aplastic anemia in siblings with multiple congenital anomalies (the Fanconi type) | Q75948943 |
| | In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: relevance to stem cell transplantation | Q80273731 |
| | Aldehyde dehydrogenase 2 activation in heart failure restores mitochondrial function and improves ventricular function and remodelling. | Q34137983 |
| | Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice | Q34198217 |
| | Recognition of the fetal alcohol syndrome in early infancy | Q34202498 |
| | Maternal aldehyde elimination during pregnancy preserves the fetal genome | Q34244123 |
| | Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function | Q34295969 |
| | Distribution of messenger RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2, and aldehyde dehydrogenase 5 in human tissues. | Q34387267 |
| | Targeting aldehyde dehydrogenase 2: new therapeutic opportunities | Q34395219 |
| | DERA is the human deoxyribose phosphate aldolase and is involved in stress response | Q34439110 |
| | Endogenous Formaldehyde Is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen. | Q34495943 |
| | Aldehyde dehydrogenase-2 regulates nociception in rodent models of acute inflammatory pain | Q34522391 |
| | Aplastic anemia in the Orient. | Q34996308 |
| | The teratogenic effects of prenatal ethanol exposure are exacerbated by Sonic Hedgehog or GLI2 haploinsufficiency in the mouse. | Q35107351 |
| | Microbial engineering for aldehyde synthesis | Q35134158 |
| | Pharmacological recruitment of aldehyde dehydrogenase 3A1 (ALDH3A1) to assist ALDH2 in acetaldehyde and ethanol metabolism in vivo | Q35189858 |
| | Structural mutation in a major human aldehyde dehydrogenase gene results in loss of enzyme activity. | Q35203034 |
| | Crosstalk between translesion synthesis, Fanconi anemia network, and homologous recombination repair pathways in interstrand DNA crosslink repair and development of chemoresistance | Q35205030 |
| | Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1 | Q35510238 |
| | Alcohol metabolism in human cells causes DNA damage and activates the Fanconi anemia-breast cancer susceptibility (FA-BRCA) DNA damage response network | Q35566416 |
| | A personalized medicine approach for Asian Americans with the aldehyde dehydrogenase 2*2 variant | Q35619842 |
| | Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease? - A mechanistic hypothesis | Q35625744 |
| | Correcting Neuromuscular Deficits With Gene Therapy in Pompe Disease | Q35903220 |
| | Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia. | Q35989456 |
| | Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach | Q36231579 |
| | Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health | Q36370381 |
| | Natural history and management of Fanconi anemia patients with head and neck cancer: A 10-year follow-up | Q36717334 |
| | Anemia of Central Origin | Q36784115 |
| | Analysis of crotonaldehyde- and acetaldehyde-derived 1,n(2)-propanodeoxyguanosine adducts in DNA from human tissues using liquid chromatography electrospray ionization tandem mass spectrometry. | Q36999501 |
| | Lessons learned about human stem cell responses to ionizing radiation exposures: a long road still ahead of us. | Q37139081 |
| | Regulation of human hematopoietic stem cell self-renewal by the microenvironment's control of retinoic acid signaling | Q37218410 |
| | Inhibition of aldehyde dehydrogenase expands hematopoietic stem cells with radioprotective capacity | Q37539087 |
| | Acetaldehyde and the genome: beyond nuclear DNA adducts and carcinogenesis | Q38166683 |
| | Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. | Q38267184 |
| | Aldehyde-modified proteins as mediators of early inflammation in atherosclerotic disease. | Q38598292 |
| | Progress toward improved therapies for inborn errors of metabolism | Q38601073 |
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Fanconi anemia | Q845779 |
| | aplastic anemia | Q846316 |
| P304 | page(s) | 28-36 | |
| P577 | publication date | 2016-09-01 | |
| P1433 | published in | Molecular Genetics and Metabolism | Q6895949 |
| P1476 | title | Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells | |
| P478 | volume | 119 | |